Immunotherapy Toxicities: Early Recognition and Management

Immune checkpoint inhibitors and adoptive cell transfer therapies have unlocked new avenues to treat cancer, but they are associated with immune-related adverse events (irAEs). Pharmacists can play an integral role in managing these irAEs and educating patients and other health care professionals about them.

The immune system recognizes tumors and eradicates cancerous